Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Our Bureau

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 24 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed’s Compensation Committee and made as a material inducement to each employee’s entry into employment with the Company.

In connection with the commencement of their employment, the employees received options on February 1, 2024 to purchase an aggregate 155,390 shares of Insmed common stock at an exercise price of $28.53 per share, the closing trading price on the Nasdaq Global Select Market on the date of grant.

The options have a 10-year term and a four-year vesting schedule, with 25% of the shares subject to the option vesting on the first anniversary of the relevant grant date and 12.5% of the shares subject to the option vesting every six months thereafter through the fourth anniversary of the relevant grant date, subject to the relevant employee’s continued service with Insmed on the applicable vesting date.

Author

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Giant Pharmacy Launches CPR Certification Program for Local Organizations and Businesses

Giant Food, the leading greater Washington, D.C. regional grocery chain, today announces the launch of its CPR Certification Program, a new service offered to local businesses and organizations. The program, offering two-year certifications led by Giant Food’s certified pharmacists, will provide the skills necessary to respond to life-threatening cardiac emergencies. The program, […]
Giant Food CPR Certification Program Launch

Subscribe Now